The RespiPoints program has ended. The program closed on June 28th, 2024.
Please refer to the Program End FAQ's at the bottom of the page if you have questions.

Thank you for your active participation in the program and gaining valuable insights
into your health. Boehringer Ingelheim is dedicated to supporting patients throughout
their treatment journey. Brand specific support is available 24/7.

Select the appropriate product below for more support.

Click below for Combivent® Respimat®
(ipratropium bromide and albuterol)

Click below for other Respimat brands

For questions related to your RespiPoints account, visit the Program End FAQ's.
You can also get assistance by emailing